KMLE
»çÀÌÆ® ¼Ò°³
°Ë»ö
°Ë»ö¾î Áö¿ì±â
´Ý±â
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
°í±Þ °Ë»ö ¼³Á¤
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
aging process
³ëȰúÁ¤
agnogenic myeloid metaplasia
¿øÀκҸí°ñ¼öÈ»ý
alcoholic cirrhosis
¾ËÄڿð£°æÈ(Áõ)
alcoholization
¾ËÄÚ¿ÃÈ
alimentary system
¼ÒȰèÅë, ¼ÒȰè
alimentary tract
¼ÒȰü
aliphatic compound
Áö¹æÁ·ÈÇÕ¹°
aliphatic hydrocarbon
Áö¹æÁ·ÅºÈ¼ö¼Ò
alkali burn
¾ËÄ®¸®È»ó
alkalization
¾ËÄ®¸®È
alkalizer
¾ËÄ®¸®ÈÁ¦
alkylating agent
¾ËųȾ๰, ¾ËųÈÁ¦
alkylation
¾ËųÈ
allergization
¾Ë·¹¸£±âÈ
alleviation
¿ÏÈ, °æ°¨
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
morphea
±¹¼ÒÇǺΰæÈÁõ, ±¹¼ÒÇǺα»À½Áõ
matching
1.¦Áþ±â, 2.Á¶È, ÀÏÄ¡
masculinization
³²¼ºÈ
mapping
ÁöµµÈ
malacia
¿¬È(Áõ)
maceration
Áþ¹«¸§, ¹°··È
palliative medicine
¿ÏÈÀÇÇÐ, °í½ÃÀÇÇÐ
squamous metaplasia
ÆíÆò»óÇÇÈ»ý
normalization
Á¤»óÈ, ±Ô°ÝÈ
neurotropic
½Å°æÄ£È-, Çâ½Å°æ-
neutralization
ÁßÈ
nitrification
Áú»ê¿°È, Áú»êÈ
nitrogen dioxide
ÀÌ»êÈÁú¼Ò
nephrosclerosis
ÄáÆÏ±»À½Áõ, ½ÅÀå°æÈÁõ
carbon dioxide narcosis
ÀÌ»êÈź¼ÒÈ¥¼ö
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
arteriosclerotic cardiovascular disease
µ¿¸Æ°æÈ½ÉÀåÇ÷°üº´
arteriosclerotic heart disease
µ¿¸Æ°æÈ½ÉÀ庴
assimilation product
µ¿È»ý»ê¹°
assimilation quotient
µ¿ÈÀ²
assimilation starch
µ¿È³ì¸»
assimilation starch grain
µ¿È³ì¸»°ú¸³
asymmetric compound
ºñ´ëĪÈÇÕ¹°
ataxic dysarthria
Á¶È¿îµ¿ºÒ´É¸»´õµëÁõ
ataxic dysphasia
Á¶È¿îµ¿¾ð¾îÀå¾Ö
ataxic gait
Á¶È¿îµ¿ºÒ´Éº¸Çà, Èçµé°ÉÀ½
ataxic hemiparesis
Á¶È¿îµ¿ºÒ´É¹ÝºÎÀü¸¶ºñ
ataxic nystagmus
Á¶È¿îµ¿ºÒ´É´«¶³¸², ¿îµ¿½ÇÁ¶´«¶³¸²
ataxic paraplegia
Á¶È¿îµ¿ºÒ´ÉÇϹݽŸ¶ºñ, Á¶È¿îµ¿ºÒ´É¾çÃø¸¶ºñ
atherosclerotic plaque
Á×»ó°æÈÆÇ
atherosclerotic heart disease
Á×»ó°æÈ½ÉÀ庴
ÀÌÀü
´ÙÀ½
Sponsored Links
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
adrenal virilism
ºÎ½Å(¼º) ³²¼ºÈ(¡Ñûàõûù).
adsorption compound
ÈíÂøÈÇÕ¹°.
advanced glycosylation end products
ÁøÇ༺´çÈÁ¾¸»»ý¼º¹°(òäú¼àõÓÐûùðûØÇßæà÷Úª)
aerification
±âÈ(Ѩûù).
affinity
ģȼº
affinity
ģȼº(öÑûúàõ), ģȷÂ(öÑûúæ³)
affinity
ģȼº(öÑûúàõ), ģȷÂ(öÑûúÕô), °áÇÕ¼º.
affinity
ģȷÂ, ģȼº
affinity chromatography
Ä£È(öÑûú) Å©·Î¸¶Åä±×¶óÇÇ.
affinity chromatography
ģȼº Å©·Î¸¶Åä±×·¡ÇÇ
affinity coefficient
ģȰè¼ö(öÑûúÌõâ¦)
affinity constant
ģȻó¼ö(öÑûúßÈâ¦)
agar streak method
ÇÑõȼ±¹ý(¡ûþàÊÛö).
age hardening
½ÃÈ¿°æÈ(ãÁüùÌãûù).
age resister
³ëȹæÁöÁ¦(ÖÕûùÛÁòð¥).
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
15
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
suppurative endophthalmitis
ȳó¾È³»¿°, ȳ󴫼ӿ°Áõ
ophthalmoblenorrhea
ȳó¾È¿°
purulent ophthalmia
ȳó¾È¿°
pyophthalmitis
ȳó¾È¿°
suppurantia =pustulantia
ȳó¾à(ûùÒÛå·).
ecpyetic
ȳóÃËÁø(ȳóÃËÁø)ÀÇ.
suppurative iridocyclitis
ȳóȫä¸ð¾çü¿°
suppurative iritis
ȳóȫä¿°
heating power
È·Â(Ì´Ëç).
heating power
È·Â(ûýæ³).
frame rate
È¸é ¹ß»ýÀ² (ûþØü Û¡ßæëÒ)
scroll
ȸé À̵¿
frame rate
ȸéÀ²
stoker s cramp
Ⱥΰæ·Ã(ûýÜýÌâÕý)
fireman s cramp
Ⱥΰæ·Ã(ûýÜýÌâÕý).
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
anabolic steroid
´Ü¹éµ¿È½ºÅ×·ÎÀ̵å.
anabolism
µ¿È(ÀÛ¿ë)(ÔÒûùíÂéÄ)
analytical chemistry
ºÐ¼®ÈÇÐ(ÝÂà°ûùùÊ).
analytical chemistry
ºÐ¼®ÈÇÐ
anamnestic
±â¾ï°È¼ºÀÇ.
androgen, androgenic steroid
³²¼º(È)È£¸£¸ó, ³²¼ºÈ½ºÅ×·ÎÀ̵å.
angiokeratoma
°¢ÈÇ÷°üÁ¾(ÊÇûùúìηðþ), ¸Æ°ü°¢ÈÁõ(ØæÎ·ÊÇûùñø)
angiokeratoma
°¢ÈÇ÷°üÁ¾(ÊÇûùúìηðþ), ¸Æ°ü°¢ÈÁõ(ØæÎ·ÊÇûùñø)
angiokeratoma circumscriptum
±¹ÇѼº °¢ÈÇ÷°üÁ¾
angiokeratoma corporis
±¸°£°¢ÈÇ÷°üÁ¾(ÏÆÊÏÊÇûùúìηðþ)
angiokeratoma corporis diffusum
Àü½Å¼º ±¸°£°¢ÈÇ÷°üÁ¾(îïãóàõÏÆÊÏÊÇûùúìηðþ)
angiokeratoma of Fordyce
Æ÷´ÙÀ̽º Ç÷°ü °¢ÈÁ¾(úìη ÊÇûùðþ)
angiokeratoma of Mibelli
¹Ìº§¸® Ç÷°ü °¢ÈÁ¾(úìη ÊÇûùðþ)
angiosclerosis
Ç÷°ü°æÈ(Áõ)
angiosclerotic necrosis
Ç÷°ü°æÈ¼º ±«»ç.
ÀÌÀü
´ÙÀ½
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÇÑÀÚ
randomization
¹«ÀÛÀ§È
ÙííÂêÓûù
rarefaction
<-> condensation(ÀÀÃà) Èñ¹ÚÈ
ýüÚÝûù
reactivation
ÀçȰ¼ºÈ
î¢üÀàõûù
redifferentiation
ÀçºÐÈ
î¢ÝÂûù
reinforcement
°È
Ëûù
remission
¿ÏÈ
èÐûú
reticulation
±×¹°È, ¸Á»óÈ
±×¹°ûù, ØÑßÒûù
sclerosis
±»À½, °æÈ
Ìãûù
¤Ñ CT
¾ÈÀåÀü»êÈ´ÜÃæÃÔ¿µ
äÓíûï³ß©ûùÓ¨öµõÉç¯
SjVO2, jugular venous oxygen saturation
°æÁ¤¸Æ»ê¼ÒÆ÷ȵµ
Ìòð¡Øæß«áÈøéûúÓø
Superoxide
°ú»êȹ°
Φ߫ûùÚª
alimentary s.
¼ÒȰè
á¼ûùͧ÷Ö
digestive s.
¼ÒȰè
á¼ûùͧ÷Ö
quantifiable t.
Á¤·®È°Ë»ç
ïÒÕáûù ËþÞÛ
tuberous sclerosis
°áÀý°æÈÁõ
Ì¿ï½àõÌãûùñø
ÀÌÀü
´ÙÀ½
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
double lysogeny
ÀÌÁß ¿ë¿øÈ(ì£ñì éÁê«ûù)
dye-sensitized photooxidation
»ö¼Ò °¨¼ö¼º ±¤»êÈ(ßäáÈÊïáôàõÎÃß«ûù)
eclosion hormone
¿ìÈ(éâûù) È£¸£¸ó
ectchemistry
Ç¥¸éÈÇÐ(øúØüûùùÊ)
efflorescence
dzÈ(ù¦ûù)
elaidinization
ÀÏ·¹À̵òÈ(ûù)
electrochemical potential
Àü±âÈÇÐÀüÀ§(ï³Ñ¨ûùùÊï³êÈ)
electromechanochemical coupling hypothesis
Àü±â±â°èÈÇÐÀû(ï³Ñ¨Ñ¦ÌþûùùÊîÜ) ¦Áþ±â¼³(àã)
electron affinity
"ÀüÀÚ Ä£È¼º(ï³íöÑûúàõ)(µµ,Óø)"
electron ionization mass spectrometry
ÀüÀÚ(ï³í)ÀÌ¿ÂÈ(ûù) Áú·® ºÐ¼®¹ý(òõÕáÝÂà°Ûö)
emulsification
¿¡¸ÖÁ¯È(ûù)
emulsifying agent
¿¡¸ÖÁ¯ÈÁ¦(ûùð¥)
energy of activation
Ȱ¼ºÈ(üÀàõûù) ¿¡³ÊÁö
energy-poor compound
ºó(Þ¸)¿¡³ÊÁö ÈÇÕ¹°(ûùùêÚª)
energy-rich compound
ºÎ(Ý£)¿¡³ÊÁö ÈÇÕ¹°(ûùùêÚª)
ÀÌÀü
´ÙÀ½
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
localization
±¹¼ÒÈ, ±¹Àç(È), Á¤À§, À§Ä¡°áÁ¤
longitudinal magnetization
Á¾ÃàÀÚÈ
lumbarization
¿äÃß°ñÈ, ¿äÃßÈ
luteinization
ȲüÈ
luteinizing hormone
ȲüÈÈ£¸£¸ó, ȲüÇü¼ºÈ£¸£¸ó
magnetic moment nulling
ÀÚ±â¸ð¸àÆ®¹«È¿È
magnetic saturation
ÀÚ±âÆ÷È
magnetic susceptibility
ÀÚ±âÈÀ²
magnetic susceptibility artefact
ÀÚ±âÈÀ²Àΰø¹°
magnetic susceptibility gradient
ÀÚ±âÈÀ²°æ»ç
magnetic susceptibility variation
ÀÚ±âÈÀ²º¯ÀÌ
magnetic transfer contrast [=MTC]
ÀÚÈÀü´Þ´ëÁ¶µµ
magnetisation transfer coherence
ÀÚÈÀü´Þ°áÁý
magnetizability
ÀÚÈ´É
magnetization
ÀÚÈ, ÀÚ±âÈ
ÀÌÀü
´ÙÀ½
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú :
5
ÆäÀÌÁö:
11
ÄÚµå
¿µ¹®
ÇѱÛ
H66.4
Suppurative otitis media, unspecified
»ó¼¼ºÒ¸íÀÇ È³ó¼º ÁßÀÌ¿°
H74.0
Tympanosclerosis
°í½Ç°æÈÁõ
H80
Otosclerosis
±Í°æÈÁõ
H80.0
Otosclerosis involving oval window, non- obliterative
³¿øÃ¢À» ħ¹üÇÏ´Â ºñÆó»ö¼º ±Í°æÈÁõ
H80.1
Otosclerosis involving oval window, obliterative
³¿øÃ¢À» ħ¹üÇÏ´Â Æó»ö¼º ±Í°æÈÁõ
ÀÌÀü
´ÙÀ½
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
¼³¸í
calcium oxide
»êÈ Ä®½·
ºÎ½Ä¼º ¾ËÄ®¸®, ºÎ½Ä¼º Åä·ùÀÇ ÀÏÁ¾. °ø±âÁßÀÇ ÀÌ»êÈź¼Ò¸¦ Èí¼öÇÏ´Â µ¥ ¾²À̸ç, °ø¾÷ÀûÀ¸·Î´Â °ª½Ñ ¾ËÄ®¸®·Î ±×¸®°í ¸ð¸£Å¸¸£ÀÇ ±âÀç·Î »ç¿ëµÈ´Ù.
calcium pyrophosphate dihydrate
À̼öÈ ÇÇ·ÎÀλê Ä®½·
calgon
°æ¼ö ¿¬ÈÁ¦
calibration curve
º¸Á¤ °î¼±, Ç¥ÁØÈ °î¼±
CAM 1. ÈÄÀ±»ó ÇÇ¿±Ù. 2. ¸¸¼º À¯Âø °úÁ¤.
camabrasion
ÈÇÐ ¿¬¸¶
Ç¥ÇÇ¿Í ÁøÇÇ »óÃþÀÇ Ç¥Ãþ ÆÄ±«¸¦ ÀÏÀ¸Å³ ¸ñÀûÀ¸·Î, ÇǺο¡ ºÎ½ÄÁ¦¸¦ Àû¿ëÇÏ´Â °Í. ¹ÝÈç, ÀÚû, ¸ð¹Ý, °¡´Â ÁÖ¸§»ì µîÀ» Á¦°ÅÇϱâ À§ÇØ ½ÃÇàÇÑ´Ù.
canceration
¾ÏÈ, ¾Ï ¹ß»ý
¾ÏÀÇ º¯Çü.
carbide
źȹ°
¿ø¼Ò ¶Ç´Â ±â¿Í °áÇÕÇÑ ÈÇÕ¹°.
carbohydrate
´çÁú, ź¼öȹ°
´Ù°¡ ¾ËÄÝ, ƯÈ÷ 5°¡ ¹× 6°¡ ¾ËÄÝÀÇ ¾Ëµ¥ÇÏÀ̵å ȤÀº Űſ À¯µµÃ¼ ¼ö¼Ò¿Í »ê¼Ò°¡ º¸Åë ¹°°ú °°Àº ºñÀ²·Î ÇÔÀ¯µÇ¹Ç·Î
carbohydrate fermentation test
ź¼öȹ° ¹ßÈ¿ ½ÃÇè
carbohydrate metabolism disorder
ź¼öȹ° ´ë»ç Àå¾Ö
carbohydrate tolerance
ź¼öȹ° ºÎÇÏ, ź¼öȹ° ³»Àμº
carbohydrate utilization test
ź¼öȹ° ÀÌ¿ë ½ÃÇè
carbon dioxide
ÀÌ»êÈź¼Ò, ź»ê °¡½º
1. ¹«Ãë, ¹«»öÀÇ ±âü. ź¼Ò¸¦ »êÈÇÏ¿© ¾ò´Â´Ù. Á¶Á÷¿¡¼ Çü¼ºµÇ¾î Æó·Î ¹èÃâµÈ´Ù. ÀÌ»êÈź¼Ò¿Í ź»ê¿°Àº ½Åü Á¶Á÷°ú ü¾×ÀÇ Áß¼ºÀ» À¯ÁöÇÏ´Â °ÍÀ» Á¶ÀýÇÏ´Â ÀÛ¿ëÀ» ÇÑ´Ù. 5-7% ź»ê °¡½º¸¦ ÇÔÀ¯ÇÏ´Â »ê¼Ò È¥ÇÕ¹° ÇüÅ·ΠȣÈíÀ» ÀÚ±ØÇϴµ¥ »ç¿ëµÇ°í ±×¿Ü °íüÇüÀ¸·Î ¾î¶² Á¾·ùÀÇ ÇǺκ´ Ä¡·á¿¡µµ »ç¿ëµÈ´Ù. 2. »ýü¿¡ ÀÇÇØ »ê¼Ò¿Í ¿µ¾ç¼Ò°¡ °áÇÕÇÒ ¶§ »ý»êµÇ´Â °¡½º¼º ³ëÆó¹°.
carbon dioxide narcosis
ÀÌ»êÈź¼Ò È¥¹ÌÁõ
carbon dioxide transport
ÀÌ»êÈź¼Ò ¿î¹Ý
ÀÌÀü
´ÙÀ½
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú :
15
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
dartist
È»ì´øÁö±â °ÔÀÓÀ» ÇÏ´Â »ç¶÷
arrowy
È»ìÀÇ;ºü¸¥
bowshot
È»ìÀÌ´ê´Â°Å¸®;»çÁ¤°Å¸®
Sagitta
È»ìÀÚ¸®(the Arrow)
arrowhead
È»ìÃË
sagittate
È»ìÃË ¸ð¾çÀÇ
flinthead
È»ìÃË(ºÎ½Ëµ¹·Î ¸¸µç)
arrowhead
È»ìÃË;¼è±Í³ª¹«¼ÓÀÇ ½Ä¹°
fossil
ȼ®
zoolite
ȼ® µ¿¹°
taphonomy
ȼ® »ý¼º(·Ð)
fossil fuel
ȼ® ¿¬·á(¼®À¯,¼®Åº,õ¿¬ °¡½º µî)
fossilize
ȼ®À¸·Î ¸¸µé´Ù;ȼ® äÁýÀ» ÇÏ´Ù;½Ã´ë¿¡ µÚÁö°Ô ÇÏ´Ù
fossiliferous
ȼ®À» ÇÔÀ¯ÇÑ
scatology
ȼ®ÀÇ ºÐ¼®ÇÐ. ¿Ü¼³¹®ÇÐ.
ÀÌÀü
´ÙÀ½
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
difficulty
°ï¶õ,ºÒÈ,³±¹
digest
¼ÒÈÇÏ´Ù; Å͵æÇÏ´Ù; Àû¿ä; ¿ä¾à
dihydr
¼ö¼Ò¿ÍÀÇ ÈÇÕ¹°ÀÎ
dihydro
¼ö¼Ò¿ÍÀÇ ÈÇÕ¹°ÀÎ
dime
(¹Ì±¹,ij³ª´Ù)10¼¾Æ® ÀºÈ
discord
ºÒÀÏÄ¡; ºÒÈ
discordance
ºÎÁ¶È
discordancy
ºÎÁ¶È
discordant
Á¶ÈÇÏÁö ¾Ê´Â
discourse
´ãÈ
disorder
ºÎÁ¶È
dissonance
ºÒÇùÈÀ½
dissonancy
ºÒÇùÈ
disulfide
ÀÌȲȹ°
disulphide
ÀÌȲȹ°
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
Á¦Ç°¸í
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
Á¦Ç°¸í
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
ÀÌÀü
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
ÀÌÀü
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÇÑÀÚ
ÀÌÀü
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
ÀÌÀü
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
ÀÌÀü
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
ÀÌÀü
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
ÄÚµå
¿µ¹®
ÇѱÛ
ÀÌÀü
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
11
¿µ¹®
ÇѱÛ
¼³¸í
ÀÌÀü
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú:
0
ÆäÀÌÁö:
11
ÀÌÀü
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú:
0
ÆäÀÌÁö:
11
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½